An Open-Label, Multicenter, Phase II Study of Bexarotene in Patients with Adult T-Cell Leukemia/Lymphoma. Yonekura K, Muto I, Takenaka M, Aoi J, et al. J Dermatol 2025;52:1619-1628.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Yonekura K, Muto I, Takenaka M, Aoi J, et al. An Open-Label, Multicenter, Phase II Study of Bexarotene in Patients with Adult T-Cell Leukemia/Lymphoma. J Dermatol 2025;52:1619-1628.
PMID: 40847644